Expert Opinion on Orphan Drugs, Volume 8, Issue 9 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Orphan Drugs, Volume 8, Issue 9 (2020)

See all volumes and issues
Vol 12, 2024 Vol 11, 2023 Vol 10, 2022 Vol 9, 2021 Volume 8, 2020 Vol 7, 2019 Vol 6, 2018 Vol 5, 2017 Vol 4, 2016 Vol 3, 2015 Vol 2, 2014 Vol 1, 2013
Download citations Download PDFs Download issue

Special issue on Rare Cancers

Foreword

Rare cancers, the continued agenda for progress – editor’s special foreword
Daniel J O’Connor
Pages: 309-310
Published online: 22 Sep 2020
CitationforRare cancers, the continued agenda for progress – editor’s special foreword | Full Text | References | PDF (152.9 KB) | EPUB
  • 1236 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

DRUG EVALUATION

Article
Tazemetostat as a treatment for epithelioid sarcoma
Mia C. Weiss & Mark Agulnik
Pages: 311-315
Published online: 24 Aug 2020
AbstractforTazemetostat as a treatment for epithelioid sarcoma | Full Text | References | PDF (349.7 KB) | EPUB
  • 91 Views
  • 6 CrossRef citations
  • 0Altmetric

Review

Hematopoietic stem cell transplantation for Langerhans cell histiocytosis: clinical findings and long-term outcomes
Akira Morimoto & Kazuko Kudo
Pages: 317-328
Published online: 24 Jun 2020
AbstractforHematopoietic stem cell transplantation for Langerhans cell histiocytosis: clinical findings and long-term outcomes | Full Text | References | PDF (1.4 MB) | EPUB
  • 24 Views
  • 1 CrossRef citations
  • 0Altmetric
Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics
Riccardo Moia, Andrea Patriarca, Abdurraouf Mokhtar Mahmoud, Valentina Ferri, Chiara Favini, Silvia Rasi, Clara Deambrogi & Gianluca Gaidano
Pages: 329-342
Published online: 16 Aug 2020
AbstractforAssessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics | Full Text | References | PDF (1.8 MB) | EPUB
  • 1459 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Diagnosis and management of uterine serous carcinoma: current strategies and clinical challenges
Omar Najjar, Britt K. Erickson & Amanda N. Nickles-Fader
Pages: 343-355
Published online: 15 Jul 2020
AbstractforDiagnosis and management of uterine serous carcinoma: current strategies and clinical challenges | Full Text | References | PDF (413.7 KB) | EPUB
  • 54 Views
  • 1 CrossRef citations
  • 0Altmetric
Assessing prognosis in cholangiocarcinoma: a review of promising genetic markers and imaging approaches
Fabio Bagante, Marzia Tripepi, Gaya Spolverato, Diamantis I. Tsilimigras & Timothy M. Pawlik
Pages: 357-365
Published online: 05 Aug 2020
AbstractforAssessing prognosis in cholangiocarcinoma: a review of promising genetic markers and imaging approaches | Full Text | References | PDF (1.3 MB) | EPUB
  • 60 Views
  • 1 CrossRef citations
  • 0Altmetric
Multiple endocrine neoplasia type 1: a review of current diagnostic and treatment approaches
Francesca Marini, Francesca Giusti, Francesco Tonelli & Maria Luisa Brandi
Pages: 367-377
Published online: 02 Sep 2020
AbstractforMultiple endocrine neoplasia type 1: a review of current diagnostic and treatment approaches | Full Text | References | PDF (386.5 KB) | EPUB
  • 51 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Current and emerging therapies for the treatment of leishmaniasis
Shyam Sundar et al.
Review Article | Published online: 1 Apr 2024
Open Access
The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022
Abraham Viju Ipe et al.
Article | Published online: 26 Mar 2024
Open Access
Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listing
Nigel S B. Rawson et al.
Article | Published online: 13 Feb 2024
Open Access
Overview of genetic testing in Prader-Willi syndrome
Ying Gao et al.
Review Article | Published online: 28 Sep 2023
Open Access